US Patent Issued to The Research Foundation for the State University of New York on Sept. 8 for "Methods and compositions for inactivating interleukin-2-inducible t-cell kinase (ITK)" (New York Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,381, issued on Sept. 8, was assigned to The Research Foundation for the State University of New York (Albany, N.Y.).

"Methods and compositions for inactivating interleukin-2-inducible t-cell kinase (ITK)" was invented by Mobin Karimi (Manlius, N.Y.) and Alaji Bah (Baldwinsville, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compositions and methods for administering a subject in need thereof an effective amount of an inhibitor of interleukin-2-inducible T-cell kinase (ITK). In embodiments, the polypeptide of the present disclosure is characterized as an inhibitor and includes an amino acid sequence having at l...